Skip to content
Home/Companies/Biotech/Mucolife Therapeutics

Mucolife Therapeutics

Biotech·Sweden·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Mucolife Therapeutics?

Mucolife Therapeutics is currently owned by GU Ventures through GU Ventures Evergreen (1995 vintage), since 2024.

Hand-verified · updated 2026-08-17

GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
SimSen Diagnostics
Active
MedTechSweden· 2020
Hydroc Energy Storage
Active
EnergySweden· 2019
Sobrera Pharma
Active
PharmaSweden· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Mucolife Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Mucolife Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Mucolife Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue